about
Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company intends to commercialize its pro...
Read More
0.35
0.00
(0.00%)
248.6K
XNAS Volume
XNAS 11 Jul, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Equillium Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..